Clinical trial
Cell Therapy for Coronary Heart Disease
NCT00289822 · Johann Wolfgang Goethe University Hospital, Other · Terminated
Key facts
| NCT number | NCT00289822 |
|---|---|
| Title | Cell Therapy for Coronary Heart Disease |
| Official title | Cell Therapy for Coronary Heart Disease: Infusion of Autologous Ex Vivo Cultivated Endothelial Progenitor Cells (EPCs)" and Autologous Bone Marrow Progenitor Cells in Crossover Design for Improvement of Vascularization and Cardiac Function |
| Lead sponsor | Johann Wolfgang Goethe University Hospital, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | intracoronary infusion of progenitor cells |
| Enrollment | 75 |
| Start date | Jan 1, 2002 |
| Completion | Jan 1, 2005 |
| First posted | Feb 10, 2006 |
| Last update posted | Nov 30, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: